|
Market Closed -
Nasdaq Stockholm
12:00:00 2026-08-21 EDT
|
5-day change | 1st Jan Change | ||
| 1.676 SEK | -3.90% |
|
+6.21% | -65.12% |
| 08-17 | Slovenia Endorses Maximum Allowed Price for Oncopeptides' Multiple Myeloma Drug Pepaxti | MT |
| 08-17 | Oncopeptides receives list price for Pepaxti in Slovenia | FW |
| Market Cap | 663M 69.96M 59.93M 56.07M 51.33M 96.33M 6.69B 97.6M 258M 3.36B 263M 257M 11.12B | P/E 2026 * |
-3.6x | P/E 2027 * | -6.84x |
|---|---|---|---|---|---|
| Enterprise Value | 707M 74.66M 63.95M 59.84M 54.78M 103M 7.14B 104M 276M 3.59B 280M 274M 11.87B | EV / Sales 2026 * |
5x | EV / Sales 2027 * | 2.98x |
| Free-Float |
96.15% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Oncopeptides AB
| 1 day | -3.90% | ||
| 1 week | +6.21% | ||
| Current month | +5.94% | ||
| 1 month | +5.54% | ||
| 3 months | +2.51% | ||
| 6 months | -9.11% | ||
| Current year | -65.12% |
| 1 week | 1.66 |  | 1.86 |
| 1 month | 1.55 | | 1.86 |
| Current year | 1.26 | | 4.91 |
| 1 year | 1.26 | | 6.55 |
| 3 years | 1.1 | | 10.2 |
| 5 years | 1.1 | | 54.7 |
| 10 years | 1.1 | | 215 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sofia Heigis
CEO | Chief Executive Officer | 46 | 2023-08-06 |
| Director of Finance/CFO | 52 | 2023-11-12 | |
Stefan Norin
CTO | Chief Tech/Sci/R&D Officer | 54 | 2023-08-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 65 | 2011-12-31 | |
| Director/Board Member | 63 | 2017-01-31 | |
Per Wold-Olsen
CHM | Chairman | 78 | 2018-05-16 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 3/20/26 | Free | Chief Technology Officer | 3,000 | 0.0008% | ||
| 10/17/25 | Free | Chairman | 254,311 | 0.0985% | ||
| 9/19/25 | Free | Chief Technology Officer | 723 | 0.0003% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.90% | +6.21% | -59.95% | -75.72% | 69.96M | |
| -3.00% | +2.27% | +73.26% | +113.08% | 72.12B | |
| +1.90% | +23.53% | +59.48% | +94.94% | 65.85B | |
| +5.12% | +25.22% | +5.13% | -5.23% | 29.28B | |
| +0.55% | +1.64% | -4.63% | +469.35% | 27.47B | |
| -4.20% | +5.81% | +46.75% | +9.51% | 26.7B | |
| +0.47% | +6.12% | +37.01% | -16.17% | 20.06B | |
| +1.82% | -6.67% | +251.36% | +388.91% | 18.22B | |
| -1.86% | +0.96% | +12.28% | +555.28% | 16.4B | |
| +0.73% | +5.54% | +39.99% | +148.64% | 13.4B | |
| Average | -0.25% | +8.15% | +46.07% | +168.26% | 28.96B | |
| Weighted average by Cap. | -0.07% | +9.48% | +57.07% | +156.29% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 141M 14.92M 12.78M 11.96M 10.95M 20.55M 1.43B 20.82M 55.1M 717M 56.03M 54.81M 2.37B | 239M 25.28M 21.66M 20.27M 18.55M 34.81M 2.42B 35.27M 93.37M 1.22B 94.94M 92.88M 4.02B |
| Net income | -147M -15.51M -13.28M -12.43M -11.38M -21.35M -1.48B -21.63M -57.26M -745M -58.22M -56.96M -2.47B | -82.33M -8.69M -7.45M -6.97M -6.38M -11.97M -832M -12.13M -32.11M -418M -32.65M -31.94M -1.38B |
| Net Debt | 44.5M 4.7M 4.03M 3.77M 3.45M 6.47M 450M 6.56M 17.35M 226M 17.65M 17.26M 747M | 51.5M 5.44M 4.66M 4.36M 3.99M 7.49M 520M 7.59M 20.08M 261M 20.42M 19.98M 865M |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-21 | SEK 1.676 | -3.90% | 1,871,471 |
| 26-08-20 | SEK 1.744 | -0.85% | 3,232,272 |
| 26-08-19 | SEK 1.759 | +3.53% | 1,886,521 |
| 26-08-18 | SEK 1.699 | -0.70% | 3,825,757 |
| 26-08-17 | SEK 1.711 | +8.43% | 9,261,888 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ONCO Stock
Select your edition
All financial news and data tailored to specific country editions
